These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16334397)

  • 21. Proton beam therapy for patients with medically inoperable stage I non-small-cell lung cancer at the university of tsukuba.
    Nakayama H; Sugahara S; Tokita M; Satoh H; Tsuboi K; Ishikawa S; Tokuuye K
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):467-71. PubMed ID: 20056349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis.
    Hata M; Tokuuye K; Sugahara S; Fukumitsu N; Hashimoto T; Ohnishi K; Nemoto K; Ohara K; Matsuzaki Y; Akine Y
    Strahlenther Onkol; 2006 Dec; 182(12):713-20. PubMed ID: 17149578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical proton radiation therapy research at the Francis H. Burr Proton Therapy Center.
    DeLaney TF
    Technol Cancer Res Treat; 2007 Aug; 6(4 Suppl):61-6. PubMed ID: 17668954
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of dose-volume histograms between proton beam and X-ray conformal radiotherapy for locally advanced non-small-cell lung cancer.
    Ohno T; Oshiro Y; Mizumoto M; Numajiri H; Ishikawa H; Okumura T; Terunuma T; Sakae T; Sakurai H
    J Radiat Res; 2015 Jan; 56(1):128-33. PubMed ID: 25368341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proton beam therapy for non-small-cell lung cancer.
    Technol Eval Cent Assess Program Exec Summ; 2011 Mar; 25(7):1-3. PubMed ID: 21638943
    [No Abstract]   [Full Text] [Related]  

  • 26. Proton beam therapy for hepatocellular carcinoma adjacent to the porta hepatis.
    Mizumoto M; Tokuuye K; Sugahara S; Nakayama H; Fukumitsu N; Ohara K; Abei M; Shoda J; Tohno E; Minami M
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):462-7. PubMed ID: 18243571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The preliminary report of a registration clinical trial of proton and heavy ion irradiation].
    Lu JD; Ye M; Guo Q; Fu JF; Moyers XM; Zhang ST; Mao NY; Kong YS; Hsi X; Shahnazi XY; Zhao JH; Zhang B; Ma JY; Lai YXZ; Zhang W; Ma J; Gao LN; Cai XM; Guan S; Zhang GL; Wu JF; Cheng L; Sheng Z; Ren XM; Zhao J; Sun L; Jiang G
    Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):52-56. PubMed ID: 29365418
    [No Abstract]   [Full Text] [Related]  

  • 28. Proton beam therapy of Stage II and III non-small-cell lung cancer.
    Nakayama H; Satoh H; Sugahara S; Kurishima K; Tsuboi K; Sakurai H; Ishikawa S; Tokuuye K
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):979-84. PubMed ID: 20888140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multi-Institutional Prospective Study of Reirradiation with Proton Beam Radiotherapy for Locoregionally Recurrent Non-Small Cell Lung Cancer.
    Chao HH; Berman AT; Simone CB; Ciunci C; Gabriel P; Lin H; Both S; Langer C; Lelionis K; Rengan R; Hahn SM; Prabhu K; Fagundes M; Hartsell W; Mick R; Plastaras JP
    J Thorac Oncol; 2017 Feb; 12(2):281-292. PubMed ID: 27826034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer.
    Chang JY; Zhang X; Wang X; Kang Y; Riley B; Bilton S; Mohan R; Komaki R; Cox JD
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1087-96. PubMed ID: 16682145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone.
    Shipley WU; Verhey LJ; Munzenrider JE; Suit HD; Urie MM; McManus PL; Young RH; Shipley JW; Zietman AL; Biggs PJ
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):3-12. PubMed ID: 7721636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the Clinical Impact of Approximations in Analytical Dose Calculations for Proton Therapy.
    Schuemann J; Giantsoudi D; Grassberger C; Moteabbed M; Min CH; Paganetti H
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1157-1164. PubMed ID: 26025779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose-volume comparison of proton radiotherapy and stereotactic body radiotherapy for non-small-cell lung cancer.
    Kadoya N; Obata Y; Kato T; Kagiya M; Nakamura T; Tomoda T; Takada A; Takayama K; Fuwa N
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1225-31. PubMed ID: 20732759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The clinical experience with particle therapy in adults.
    Schulz-Ertner D
    Cancer J; 2009; 15(4):306-11. PubMed ID: 19672147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First Clinical Report of Proton Beam Therapy for Postoperative Radiotherapy for Non-Small-Cell Lung Cancer.
    Remick JS; Schonewolf C; Gabriel P; Doucette A; Levin WP; Kucharczuk JC; Singhal S; Pechet TTV; Rengan R; Simone CB; Berman AT
    Clin Lung Cancer; 2017 Jul; 18(4):364-371. PubMed ID: 28162946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of proton beam therapy without concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer.
    Oshiro Y; Mizumoto M; Okumura T; Hashimoto T; Fukumitsu N; Ohkawa A; Kanemoto A; Hashii H; Ohno T; Sakae T; Tsuboi K; Sakurai H
    J Thorac Oncol; 2012 Feb; 7(2):370-5. PubMed ID: 22157368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term outcome of proton therapy and carbon-ion therapy for large (T2a-T2bN0M0) non-small-cell lung cancer.
    Iwata H; Demizu Y; Fujii O; Terashima K; Mima M; Niwa Y; Hashimoto N; Akagi T; Sasaki R; Hishikawa Y; Abe M; Shibamoto Y; Murakami M; Fuwa N
    J Thorac Oncol; 2013 Jun; 8(6):726-35. PubMed ID: 23459403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer.
    Hatayama Y; Nakamura T; Suzuki M; Azami Y; Ono T; Yabuuchi T; Hayashi Y; Kimura K; Hirose K; Wada H; Hareyama M; Kikuchi Y; Takai Y
    Clin Lung Cancer; 2016 Sep; 17(5):427-432. PubMed ID: 26725851
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proton beam therapy for large hepatocellular carcinoma.
    Sugahara S; Oshiro Y; Nakayama H; Fukuda K; Mizumoto M; Abei M; Shoda J; Matsuzaki Y; Thono E; Tokita M; Tsuboi K; Tokuuye K
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):460-6. PubMed ID: 19427743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas : Ablative dose PBT for NSCLC.
    Lee SU; Moon SH; Cho KH; Pyo HR; Kim JY; Kim DY; Kim TH; Suh YG; Kim YJ
    Strahlenther Onkol; 2016 Sep; 192(9):649-57. PubMed ID: 27282279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.